M&A

Innoviva to Acquire La Jolla Pharmaceutical Company
Businesswire
Mon, 07/11/22 - 10:45 am
Innovia
La Jolla Pharmaceutical
M&A
Vertex Pharma (VRTX) to Acquire ViaCyte for $320 Million
Street Insider
Mon, 07/11/22 - 10:42 am
Vertex Pharmaceuticals
M&A
ViaCyte
type 1 diabetes
stem cells
After a lengthy drought, could biotech M&A be on the upswing?
BioPharma Dive
Fri, 07/8/22 - 11:13 am
M&A
Radius, fending off activists, outlines pitch for $890 million buyout
BioPharma Dive
Fri, 07/8/22 - 10:44 am
Radius Health
M&A
activists
Korean diagnostics biotech goes Trans-Pacific, agreeing to shell out $1.5B to take US diagnostics maker private
Endpoints
Fri, 07/8/22 - 10:42 am
diagnostics
COVID-19
Meridian Bioscience
M&A
SD Biosensor
6 Medtech Acquisitions That Went Horribly Wrong
Medical Devices and Diagnostics Industry
Thu, 07/7/22 - 08:10 pm
devices
Medtech
M&A
Medtronic
HeartWare
Second Sight Medical
Pixium Vision
Illumina
PacBio
Novartis
Alcon
Transcend
Organovo
Tarveda Therapeutics
Boston Scientific
Guidant
Portage Adds Four Adenosine Candidates to Pipeline in Tarus Buyout
BioSpace
Thu, 07/7/22 - 06:31 pm
Portage
immuno-oncology
Tarus Therapeutics
M&A
adenosine
Report: Merck in Advanced Talks to Acquire Seagen for $40B
BioSpace
Thu, 07/7/22 - 10:43 am
Merck
M&A
Seagen
oncology
How Pfizer CEO Bourla's evening call brought Biohaven back into the M&A fold
Fierce Pharma
Wed, 07/6/22 - 11:01 am
Pfizer
Pfizer CEOs
Albert Bourla
M&A
Biohaven
SEC
Two cancer biotechs merge, raise cash as sector-wide downturn continues
BioPharma Dive
Tue, 07/5/22 - 11:45 pm
Syros Pharmaceuticals
Tyme Technologies
M&A
cancer
oncology
AstraZeneca agrees $1.3bn deal to buy oncology player TeneoTwo
Pharmaforum
Tue, 07/5/22 - 11:57 am
AstraZeneca
TeneoTwo
M&A
hematologic cancers
Biopharma takeout spend ticks up
EP Vantage
Tue, 07/5/22 - 11:02 am
M&A
biotech
Pfizer
Biohaven
Bristol Myers Squibb
Turning Point Therapeutics
GSK
Affinivax
Sierra Oncology
Halozyme Therapeutics
Antares Pharma
Novartis, staring down tough market for M&A, leans toward $25B Sandoz spinoff: Bloomberg
Fierce Pharma
Fri, 07/1/22 - 09:49 am
Novartis
spinoffs
generics
M&A
Sandoz
private equity
Big Pharma not Likely to Bail Out Battered Biotech Industry
BioSpace
Thu, 06/30/22 - 11:08 am
biotech
funding
M&A
The trigger for a Seagen buyout
EP Vantage
Thu, 06/30/22 - 10:55 am
Merck
Seagen
M&A
Amgen sells its Turkish manufacturing arm for $135M
Endpoints
Wed, 06/29/22 - 05:35 pm
Amgen
Turkey
M&A
Gensenta
drug manufacturing
M&A landscape is tilting away from late-stage buys and toward a platform strategy: analysts
Fierce Pharma
Tue, 06/28/22 - 10:45 am
M&A
Accenture
Bristol Myers Squibb
MyoKardia
Ipsen beefs up in oncology, buying US biopharma Epizyme
Pharmaforum
Mon, 06/27/22 - 10:52 am
Ipsen
M&A
Epizye
Tazverik
cancer
oncology
VC firms take osteoporosis drugmaker Radius Health private for almost $900M
Endpoints
Mon, 06/27/22 - 10:04 am
Radius Health
M&A
venture capital
osteoporosis
Acquisition in the air? Merck and Seagen to meet this week: WSJ
Fierce Pharma
Fri, 06/24/22 - 12:22 pm
Merck
Seagen
M&A

Pages